A beam of light is revolutionizing skin care, targeting dermatological conditions with precision and promise. In 2023, the global dermatology excimer laser market shone at USD 584.5 million, and it's projected to illuminate the healthcare landscape with a robust 10.3% CAGR from 2024 to 2030. This growth is significantly powered by the increasing prevalence of skin disorders like psoriasis and vitiligo, creating a strong demand for effective solutions. Moreover, a growing preference for non-invasive treatments, which excimer lasers elegantly provide with minimal downtime, is further fueling this market's expansion.
Technological leaps in laser systems have not only enhanced the safety and efficacy of these treatments but also broadened their appeal to both patients and healthcare providers. The increasing health awareness among the populace and the growing adoption of laser-based treatments in dermatology clinics and skincare centers are also significant factors contributing to this market's vibrant growth.
Innovations in laser systems, such as adjustable beam sizes and enhanced targeting capabilities, are refining treatment outcomes and improving patient comfort. These advancements allow for the precise delivery of UV light to affected areas, carefully avoiding surrounding healthy skin, thereby making treatments more effective for conditions like psoriasis and vitiligo.
Get a preview of the latest developments in the Dermatology Excimer Laser Market; Download your FREE sample PDF copy today and explore key data and trends
Furthermore, improvements in pulse duration have not only boosted treatment efficacy but also minimized patient discomfort. The emergence of portable and handheld excimer laser devices offers greater flexibility and convenience in treatment settings, empowering dermatologists to perform procedures with ease and precision.
Looking to the future, the integration of artificial intelligence into excimer laser technology promises to unlock even greater potential. AI-powered systems will enable the creation of customized treatment plans tailored to the unique needs of each patient, further enhancing the precision and effectiveness of these light-based therapies.
Detailed Segmentation
Product Insights
The trolley-mounted excimer laser segment accounted for a revenue share of 43.6% in 2023 attributed to its versatility and efficiency in treating various skin conditions, including psoriasis, vitiligo, and atopic dermatitis. Trolley-mounted excimer lasers are favored in clinical settings due to their robust design, ease of mobility, and the ability to deliver precise, high-intensity UVB light to targeted areas of the skin. These features make them a preferred choice for dermatologists seeking reliable and effective treatment options for their patients.
Application Insights
Psoriasis held the largest market revenue share in 2023. The effectiveness of excimer lasers in targeting and treating localized psoriasis lesions has made them a preferred treatment option. The high demand for effective and non-invasive treatment options for psoriasis has driven the adoption of excimer lasers, contributing to the substantial market share of this segment.
End-use Insights
Dermatology clinics dominated the market in 2023. The prevalence of skin disorders such as psoriasis, vitiligo, and eczema, along with the increasing demand for effective and minimally invasive treatment methods, has propelled the adoption of excimer lasers in these clinical settings. Patients favor dermatology clinics due to their comprehensive care, customized treatment plans, and access to advanced laser therapies.
Regional Insights
North America dermatology excimer laser market dominated the global market with a revenue share of 38.2% in 2023 attributed to the high prevalence of skin disorders, advanced healthcare infrastructure, and the presence of key market players in the region. The increasing awareness about skin health and the availability of advanced treatment options have driven the demand for excimer lasers. Additionally, the region’s strong focus on research and development, coupled with favorable reimbursement policies, has further bolstered the market growth. The high adoption rate of innovative dermatological treatments in North America underscores its leading position in the global market.
Key Dermatology Excimer Laser Company Insights
The global dental articulators market is driven by several key companies, including Ra Medical Systems, Inc., Shenzhen GSD Tech Co., Ltd., Alma Lasers, Strata Skin Sciences, Inc., and The Daavlin Company, among others.
- Ra Medical Systems specializes in excimer laser technologies for dermatology and vascular applications. Their Pharos excimer laser system is highly regarded for its ability to deliver targeted UVB light therapy, providing relief for patients with chronic skin conditions.
- Strata Skin Sciences offers the XTRAC excimer laser system, which is widely used to treat psoriasis, vitiligo, and atopic dermatitis.
Key Dermatology Excimer Laser Companies:
The following are the leading companies in the Dermatology Excimer Laser market. These companies collectively hold the largest market share and dictate industry trends.
- Ra Medical Systems, Inc.
- Shenzhen GSD Tech Co., Ltd.
- Alma Lasers (Shanghai FosunPharmaceutical Group Co., Ltd.)
- Strata Skin Sciences, Inc.
- The Daavlin Company
- Fotona d.o.o.
- Beijing Sincoheren S&T Development Co., Ltd
- Lumenis, Ltd.
- Hologic, Inc.
- DEKA Research & Development Corp.
Dermatology Excimer Laser Market Segmentation
Grand View Research has segmented global dermatology excimer market report based on product, application, end-use, and region:
Dermatology Excimer Laser Product Outlook (Revenue, USD Million, 2018 - 2030)
- Table top Excimer Lasers
- Hand-held Excimer Lasers
- Trolley Mounted Excimer Lasers
Dermatology Excimer Laser Application Outlook (Revenue, USD Million, 2018 - 2030)
- Psoriasis
- Vitiligo
- Atopic Dermatitis
- Allergic Rhinitis
- Alopecia Areata
- Others
Dermatology Excimer Laser End-use Outlook (Revenue, USD Million, 2018 – 2030)
- Hospitals
- Dermatology Clinics
- Plastic Surgery Centers
Dermatology Excimer Laser Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Denmark
- Sweden
- Norway
- Asia Pacific
- India
- Japan
- China
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Curious about the Dermatology Excimer Laser Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends.
Recent Developments
- In July 2024, STRATA Skin Sciences Inc. announced that its XTRAC Momentum 1.0 device has received approval from Japan's Ministry of Health, Labor, and Welfare. The company plans to immediately commercialize it in Japan through its long-standing partner, JMEC Co. Ltd.
Comments
0 comment